Skip to main content
. 2017 Oct 10;8(59):99990–100001. doi: 10.18632/oncotarget.21725

Figure 3. A set of six salivary miRNAs that can discriminate the early stage (Stages I&II) of HPV-positive HNSCC patients from the healthy control smoker and non-smoker group.

Figure 3

*P<0.05 and **P<0.01.